Detection of MUC1 and keratin 19 mRNAs in the bone marrow by quantitative RT-PCR predicts the risk of distant metastasis in breast cancer patients
- 57 Downloads
Early detection of micrometastasis in bone marrow is critical for the prognosis of breast cancer patients. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) has been used to detect cancer cells in bone marrow, but its utility as a prognostic factor still remains obscure.
Materials and Methods
Bone marrow samples were aspirated from the anterosuperior iliac spine of 34 patients, immediately after their surgical procedures had been completed. Control samples were also obtained from 10 healthy adult volunteers. The total RNA was extracted from the mononuclear cells, and the expression levels of β-actin, MUC1 and keratin 19 mRNAs were studied by quantitative RT-PCR. Each mRNA level was scored according to the expression level. The sum of these expression scores was defined as the composite expression score, which was employed as the basis of the evaluation.
The mean follow-up period was 45 months. Nine patients developed distant metastases, and one developed local recurrence. The 4-year disease relapse rates were 75% (RR= 19.38; 95% CI: 1.94-193.20), 28% (RR=3.64; 95% CI: 0.43-31.18), and 8.3% for patients with composite expression scores of 5/6, 3/4 and 2, respectively. The difference among the three groups was statistically significant (log-rank test:p = 0.0029), and multivariate analysis also found the composite expression score to be an independent prognostic factor.
Breast cancer patients who show a high composite expression score in bone marrow have a significantly higher risk of recurrence.
Key wordsBone marrow Micrometastases Quantitative RT-PCR MUC1 Keratin 19
Reverse transcriptase-polymerase chain reaction
- 3).Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.Clin Oncol 9: 1794–1756, 1991.Google Scholar
- 8).Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CRM, Gastoph S, Wischnik A, Dimpfl T, Kindermann G, Roethmuller G, Schlimok G: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.N Engl J Med 342: 525–533, 2000.PubMedCrossRefGoogle Scholar
- 9).Gerber B, Krause A, Muller H, Richter D, Reimer T, Makovitzky J, Herrning C, Jeschke U, Kundt G, Friese K: Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors.Clin Oncol 19: 960–971, 2001.Google Scholar
- 11).Moss TJ, Sanders DJ: Detection of neuroblastoma cells in blood.Clin Oncol 8: 736–740, 1990.Google Scholar
- 14).Jauch KW, Heiss MM, Gruetzner U, Funke I, Pantel K, Babic R, Eissner HJ, Roethmuller G, Schilberg FW: Prognostic significance of bone marrow micrometastases in patients with gastric cancer.Clin Oncol 14: 1810–1817, 1996.Google Scholar
- 18).Datta YH, Adams PT, Drobyski WR, Either SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.Clin Oncol 12: 475–482, 1994.Google Scholar
- 19).Schoenfeld A, Kruger KH, Gomm J, Gazet JC, Sacks N, Bender HG, Luqmani Y, Coombes RC: The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.Eur J Cancer 33: 854–861, 1997.PubMedCrossRefGoogle Scholar
- 20).Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schlimok G, Reithmuller G, Pantel K: Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.Clin Oncol 15: 2701–2708, 1997.Google Scholar
- 22).Rosen PP, Saigo PE, Braun DW, Weathers E, DePalo A: Prediction of recurrence in stage I (T1N0M0) breast carcinoma.Cancer 193: 15–25, 1981.Google Scholar
- 24).Miura S: The prognostic significance of axillary node metastasis in breast cancer.Jpn J Breast Cancer 10: 452–459, 1995.Google Scholar
- 30).Brugger W, Buhring HJ, Grunebach F, Vogel W, Muller R, Brummendorf TH, Ziegler BL, Brossat P, Scheding S, Kanz L: Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells.Clin Oncol 17: 1535–1544, 1999.Google Scholar